In the realm of modern medicine, we find ourselves on the brink of an exciting frontier where unassuming tear fluid harbors remarkable potential as a wellspring of biomarkers.  Tear biomarkers, with their non-invasive nature and ease of collection, offer a transformative approach to early disease detection and management. As we venture into this tear-driven frontier, we anticipate groundbreaking advancements that will reshape healthcare practices and enhance our understanding of diseases' inner workings.